+44-7482878454

Recommended Conferences

International Conference on Clinical Pharmacy

London, UK

Global Meet on Pharmaceutical Sciences

Zurich, Switzerland

Prevalence of Type 2 Diabetes Associated Complications in Kurdistan Region Iraq

Author(s): Nojdar Salahuddin M Ali, Omer QB Allela*, Hishyar Mohammed Salih and Idris Haji Ahmed

Background and aim: Diabetes Mellitus (DM) complications are increasing among patients of Kurdistan region of Iraq creating a growing public health concern. The study aimed to determine the prevalence of DM complications among Kurdistan region provinces and the associated factors.

Methods: A cross-sectional study design was chosen. A total of 5186 diabetic patients were selected for this study from the three provinces of Kurdistan region of Iraq (Duhok, Erbil and Suleimania). The data collected from the files of patients registered at the diabetic centers in each of the mentioned provinces were retrospectively extracted to obtain a complete history of each individual patient.

Results: The majority of the diabetic patients had hyperlipidemia (38.4%) and hypertension (37.7%) as complications, and about (0.7%) of the diabetic patients had stroke. A significant association was found between some of DM complications with demographic variables. This study showed highly significantly differences in diabetic laboratory tests among other variable groups (DM types, duration and the body mass index BMI). The results obtained indicated that the levels of HbA1c, fasting blood sugar (FBS) and random blood sugar (RBS) showed a significant increase (positive correlation) with the duration of the disease.

Conclusion: The common chronic complications among the selected patients were hyperlipidemia, hypertension, chronic heart disease (CHD), nephropathy and neuropathy. Early screening is highly recommended for any patient with suspected DM. Lifestyle changes to lose weight are important in both treating and preventing DM and to prevent the development of DM complications such as hypertension, hyperlipidemia, neuropathy and nephropathy.


Full-Text | PDF